insights_auto
Why is TMCI down 16.13%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
US$4.42
arrow_downward
-16.13%(-0.85) 1D
US$4.58
arrow_upward
+3.62% (+0.16)bedtimeAfter hours
Closed: ኖቬም 16, 4:00:00 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
US$5.23
High
US$5.36
Low
US$4.37
Mkt. cap
289.77 ሚ
Avg. vol.
298.58 ሺ
Volume
410.85 ሺ
52-wk high
US$5.43
52-wk low
US$1.17
EPS
-US$0.86
Beta
1.59
Shares outstanding
65.56 ሚ
No. of employees
450
Open
US$5.23
High
US$5.36
Low
US$4.37
Mkt. cap
289.77 ሚ
Avg. vol.
298.58 ሺ
Volume
410.85 ሺ
52-wk high
US$5.43
52-wk low
US$1.17
EPS
-US$0.86
Beta
1.59
Shares outstanding
65.56 ሚ
No. of employees
450
News stories
From web sources and news partners
Stocktwits
·
ከ39 ደቂቃዎች በፊት
Dow, S&P 500, Nasdaq Futures Mixed Ahead Of Much-Anticipated Nvidia Earnings, Anthropic IPO: SLS, BABA, JPM, OMER In Focus
ChartMill
·
ከ8 ሰዓቶች በፊት
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
Yahoo Finance
·
ከ6 ሰዓቶች በፊት
Morgan Stanley resets S&P 500 target for 2027 as tech stocks slide
Traders Union
·
ከ4 ሰዓቶች በፊት
Airline shares post double-digit gains while S&P 500 falls, Phil Rosen notes
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc